HHS Public Access Author manuscript Author Manuscript
J Vasc Surg. Author manuscript; available in PMC 2017 April 01. Published in final edited form as: J Vasc Surg. 2016 April ; 63(4): 1121–5.e2. doi:10.1016/j.jvs.2015.12.026.
Design and Initial Enrollment in the Vascular Physicians Offer and Report (VAPOR) Trial Emily Spangler, MD1, Benjamin S. Brooke, MD, PhD2, Adam W. Beck, MD3, Andrew Hoel, MD4, Alik Farber, MD5, and Philip P. Goodney, MD, MS1 1Dartmouth
Hitchcock Medical Center, Lebanon NH
Author Manuscript
2The
University of Utah School of Medicine, Salt Lake City, UT
3The
University of Florida Section of Vascular Surgery
4Northwestern 5Boston
Memorial Hospital, Chicago, IL
Medical Center
Abstract
Author Manuscript
While smoking cessation is a key priority for vascular surgeons, significant variation exists in the manner in which vascular surgeons address this key process of care. We describe a multicenter, cluster-randomized trial which compares a standardized, brief smoking cessation intervention to usual care for patients facing vascular surgery or endovascular interventions. Eight centers were randomized to provide either usual care for smoking cessation or a standardized protocol consisting of (1) physician “very brief advice” to stop smoking, (2) offering nicotine replacement therapy (NRT), and (3) referral to a phone-based counseling service. Trial enrollment began on September 1, 2014. At present, 142 patients had been enrolled in the trial across 8 sites. Compared to patients in the usual care arm, patients enrolled in the smoking cessation intervention arm were more likely to receive physician advice (98% versus 77%), a prescription for NRT (77% versus 13%) and quitline referral (93% versus 33%) (all p
J Vasc Surg. Author manuscript; available in PMC 2017 April 01. Published in final edited form as: J Vasc Surg. 2016 April ; 63(4): 1121–5.e2. doi:10.1016/j.jvs.2015.12.026.
Design and Initial Enrollment in the Vascular Physicians Offer and Report (VAPOR) Trial Emily Spangler, MD1, Benjamin S. Brooke, MD, PhD2, Adam W. Beck, MD3, Andrew Hoel, MD4, Alik Farber, MD5, and Philip P. Goodney, MD, MS1 1Dartmouth
Hitchcock Medical Center, Lebanon NH
Author Manuscript
2The
University of Utah School of Medicine, Salt Lake City, UT
3The
University of Florida Section of Vascular Surgery
4Northwestern 5Boston
Memorial Hospital, Chicago, IL
Medical Center
Abstract
Author Manuscript
While smoking cessation is a key priority for vascular surgeons, significant variation exists in the manner in which vascular surgeons address this key process of care. We describe a multicenter, cluster-randomized trial which compares a standardized, brief smoking cessation intervention to usual care for patients facing vascular surgery or endovascular interventions. Eight centers were randomized to provide either usual care for smoking cessation or a standardized protocol consisting of (1) physician “very brief advice” to stop smoking, (2) offering nicotine replacement therapy (NRT), and (3) referral to a phone-based counseling service. Trial enrollment began on September 1, 2014. At present, 142 patients had been enrolled in the trial across 8 sites. Compared to patients in the usual care arm, patients enrolled in the smoking cessation intervention arm were more likely to receive physician advice (98% versus 77%), a prescription for NRT (77% versus 13%) and quitline referral (93% versus 33%) (all p
